Enhancer hijacking emerges as a major “missing driver” mechanism in LBCL/PCN, enabling detection of non-chimeric oncogene activation such as IGL::BCL2, IGH::CCND2, and MAFA/MAFB rearrangements.

Are you attending the ABRF Annual Meeting 2026? Here are the breakout sessions and workshops you won’t want to miss.

Integrative high-throughput studies identify novel targets and drugs for advanced prostate cancer treatment Prostate cancer, a prevalent malignancy ...

This activity was supported by the National Science Foundation under Award Number 1927620. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily ...

In Michigan Tech's biology teaching lab, undergraduate students research potential cancer cures with help from the humble worm.

Glycosylation research is steadily emerging as a critical area in the field of tumor immunology, offering fresh insights into how cancers subvert immune ...

Investigators at CHOP and UPenn found that lower cell counts could still be associated with poor outcomes if the cells were poorly differentiated.

Aromatic medicinal plants derive their therapeutic value from complex mixtures of volatile compounds, yet the genetic logic that shapes these chemical profiles has long remained elusive.

Researchers at the University of California San Diego have identified new genetic variants associated with autism spectrum ...

Researchers from the University of Oxford have created the first high-resolution molecular atlas of the adult Drosophila ...